Please use this identifier to cite or link to this item:
Title: Bleeding due to an acquired inhibitor of platelet associated factor V.
Austin Authors: Grigg, Andrew P ;Dauer, R;Thurlow, P J
Affiliation: Austin Hospital, Melbourne, Australia
Issue Date: 1-Aug-1989
Publication information: Australian and New Zealand Journal of Medicine; 19(4): 310-4
Abstract: Factor V inhibitors are uncommon, bleeding manifestations variable and recommendations for management are unclear. We present a patient with non-Hodgkins lymphoma who developed gastrointestinal bleeding and was found to have a Factor V inhibitor. The inhibitor was active against both plasma Factor V and platelet associated Factor V, and was associated with a five-fold increase in platelet associated IgG. Fresh frozen plasma was ineffective in preventing bleeding. Resolution of bleeding was associated with a fall in the levels of the inhibitor and of platelet associated IgG. The patient had no further bleeding episodes nor evidence of progression of his lymphoma, but six months later died as a result of metastatic adenocarcinoma.
Gov't Doc #: 2675811
Type: Journal Article
Subjects: Adenocarcinoma.secondary
Blood Coagulation Disorders.blood.complications
Blood Coagulation Factors.antagonists & inhibitors
Blood Platelets.metabolism
Factor V Deficiency.blood.complications
Gastrointestinal Hemorrhage.blood.etiology
Immunoglobulin G.metabolism
Leukemia, Lymphocytic, Chronic, B-Cell.complications
Partial Thromboplastin Time
Platelet Factor 3.antagonists & inhibitors
Prothrombin Time
Appears in Collections:Journal articles

Show full item record

Page view(s)

checked on Nov 25, 2022

Google ScholarTM


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.